CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

POSTER | Tumor Immunology: Examining the Microenvironment

Read More
All Posts

The immune system is tasked with distinguishing ‘self’ from ‘non-self’. Tumors can, quite often, be highly immunogenic as a result of their mutational burden, which can make them appear less like ‘self’.

However, the ability of the immune system to mount a robust anti-tumor response is undermined by the aberrant expression of suppressive proteins on the surface of the tumor and in its microenvironment, as well as co-inhibitory molecules on the surface of T lymphocytes.

Tumor-Immunology-Banner-Blog

Tumor growth and propagation is fostered by a number of intertwined pathological phenomena: immune subversion (upregulation of immune checkpoints), chronic inflammation, hypoxia-induced angiogenesis, remodeling of the extracellular matrix (ECM) and epithelial-to-mesenchymal transition (EMT). These processes, and the cells (regulatory T cells (Treg), myeloid-derived suppressor cells (MDSC), and M2 macrophages) and secretory molecules (chemokines and cytokines) that support them constitute the tumor microenvironment.

Despite the suppressive microenvironment of the tumor, immune infiltrates in the form of tumor infiltrating lymphocytes (TILs) and tertiary lymphoid structures have been associated with positive clinical outcome. In these settings the primary immune protagonists that mediate an adaptive anti-tumor response are the CD8+ cytotoxic T lymphocytes (CTLs), with natural killer (NK) cells being their innate counterpart. Humanized neutralizing antibodies targeting the immune checkpoint receptors on TILs, otherwise known as checkpoint inhibitors, have proven tremendously successful in provoking a meaningful therapeutic response.

This poster features the complex interplay of the various cellular components of the tumor microenvironment, with particular emphasis on tumor infiltrating lymphocytes and mechanisms of immune suppression.

The poster also highlights the following intercellular interactions and immunological phenomena:

  • Receptor-ligand complexes involved in T and B cell activation
  • Co-stimulatory interactions
  • Co-inhibitory interactions
  • Activation of the STING pathway
  • Immune subversion

View the Tumor Immunology: Examining the Microenvironment poster:

 


You can also download other tumor microenvironment-related resources including:

  • Our Application Note describing how multiplex IHC can be used to examine immune checkpoint proteins and T cell exhaustion markers in the tumor microenvironment.
  • Our Application Note focusing on protocol considerations for tyramide signal amplification in multiplex IHC.
  • Highly Multiplexed IHC Assays to Examine Immune Checkpoints and Biomarkers for Immunotherapy (Research Poster)

Cell Signaling Technology
Cell Signaling Technology
Cell Signaling Technology (CST) is a different kind of life science company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor. CST is a company of caring people driven by a devotion to facilitating good science—a company committed to doing the right thing for our customers, our communities, and our planet.

Recent Posts

Immunology: What are myeloid cells and how are they identified?

During hematopoiesis, myeloid cells develop from a common myeloid progenitor (CMP) found in the bone marr...
Rob MacDonald, PhD May 21, 2025

Your Antibody Toolbox for Neurodegenerative Disease Biomarker Research with Biofluid Samples

Neurodegenerative disease research is in serious need of reliable biomarkers—whether to develop methods f...
Supriya Singh, PhD May 14, 2025

Setting the Standard: CST's Commitment to Antibody Validation Through YCharOS

Within the complex landscape of biomedical research, antibodies stand as critical tools for scientific di...